These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31011634)

  • 1. Evaluation of Vascular Event Risk while on Long-term Anti-retroviral Suppressive Therapy [EVERLAST]: Protocol for a prospective observational study.
    Sarfo FS; Nichols M; Gebregziabher M; Tagge R; Asibey SO; Jenkins C; Ovbiagele B
    eNeurologicalSci; 2019 Jun; 15():100189. PubMed ID: 31011634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana.
    Sarfo FS; Nichols M; Agyei B; Singh A; Ennin E; Nyantakyi AD; Asibey SO; Tagge R; Gebregziabher M; Jenkins C; Ovbiagele B
    J Neurol Sci; 2019 Feb; 397():103-111. PubMed ID: 30599299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with incidence of stroke and heart failure among people living with HIV in Ghana: Evaluating Vascular Event Risk while on Long-Term Antiretroviral Suppressive Therapy (EVERLAST) Study.
    Sarfo FS; Norman B; Appiah L; Ovbiagele B
    J Clin Hypertens (Greenwich); 2021 Jun; 23(6):1252-1259. PubMed ID: 33939257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk and endothelial function in people living with HIV/AIDS: design of the multi-site, longitudinal EndoAfrica study in the Western Cape Province of South Africa.
    Strijdom H; De Boever P; Walzl G; Essop MF; Nawrot TS; Webster I; Westcott C; Mashele N; Everson F; Malherbe ST; Stanley K; Kessler HH; Stelzl E; Goswami N
    BMC Infect Dis; 2017 Jan; 17(1):41. PubMed ID: 28061822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Disease Burden in Rural Africa: Does HIV and Antiretroviral Treatment Play a Role?: Baseline Analysis of the Ndlovu Cohort Study.
    Vos AG; Barth RE; Klipstein-Grobusch K; Tempelman HA; Devillé WLJ; Dodd C; Coutinho RA; Grobbee DE;
    J Am Heart Assoc; 2020 Apr; 9(7):e013466. PubMed ID: 32223395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
    Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the reactivation of herpesviruses and inflammation as cardiovascular and cerebrovascular risk factors in antiretroviral therapy initiators in an African HIV-infected population (RHICCA): a protocol for a longitudinal cohort study.
    Peterson I; Ntsui N; Jambo K; Kelly C; Huwa J; Afran L; Tatuene JK; Pett S; Henrion MYR; Van Oosterhout J; Heyderman RS; Mwandumba H; Benjamin LA;
    BMJ Open; 2019 Sep; 9(9):e025576. PubMed ID: 31515413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV and risk of cardiovascular disease in sub-Saharan Africa: Rationale and design of the Ndlovu Cohort Study.
    Vos A; Tempelman H; Devillé W; Barth R; Wensing A; Kretzschmar M; Klipstein-Grobusch K; Hoepelman A; Tesselaar K; Aitken S; Madzivhandila M; Uiterwaal C; Venter F; Coutinho R; Grobbee DE
    Eur J Prev Cardiol; 2017 Jul; 24(10):1043-1050. PubMed ID: 28379043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and its effects on endothelium in HIV-positive patients in sub-Saharan Africa: Cardiometabolic risk, thrombosis and vascular function (ENDOCOVID STUDY).
    Goswami N; Fredriksen PM; Lundin KEA; Agu C; Elias SO; Motaung KS; Brix B; Cvirn G; Sourij H; Stelzl E; Kessler HH; Saloň A; Nkeh-Chungag B
    BMC Infect Dis; 2021 Jul; 21(1):719. PubMed ID: 34332551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different cardiovascular risk tools used in HIV patient cohorts in sub-Saharan Africa; do we need to include laboratory tests?
    Mubiru F; Castelnuovo B; Reynolds SJ; Kiragga A; Tibakabikoba H; Owarwo NC; Kambugu A; Lamorde M; Parkes-Ratanshi R
    PLoS One; 2021; 16(1):e0243552. PubMed ID: 33507945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis in subjects newly diagnosed with human immunodeficiency virus infection.
    Kirichenko TV; Myasoedova VA; Shimonova TE; Melnichenko AA; Sviridov D; Sobenin IA; Mazus AI; Orekhov AN; Bukrinsky MI
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29961673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
    Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
    PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda.
    Ssinabulya I; Kayima J; Longenecker C; Luwedde M; Semitala F; Kambugu A; Ameda F; Bugeza S; McComsey G; Freers J; Nakanjako D
    PLoS One; 2014; 9(2):e89537. PubMed ID: 24586854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls.
    Mosepele M; Hemphill LC; Moloi W; Moyo S; Nkele I; Makhema J; Bennett K; Triant VA; Lockman S
    PLoS One; 2017; 12(6):e0179994. PubMed ID: 28662159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and incidence of pre-diabetes and diabetes mellitus among people living with HIV in Ghana: Evidence from the EVERLAST Study.
    Sarfo FS; Norman B; Nichols M; Appiah L; Osei Assibey S; Tagge R; Ovbiagele B
    HIV Med; 2021 Apr; 22(4):231-243. PubMed ID: 33174302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review.
    Hyle EP; Mayosi BM; Middelkoop K; Mosepele M; Martey EB; Walensky RP; Bekker LG; Triant VA
    BMC Public Health; 2017 Dec; 17(1):954. PubMed ID: 29246206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Lower Adiponectin Plasma Levels, Increased Age and Smoking with Subclinical Atherosclerosis in Patients with HIV-1 Infection.
    Bellinati PQ; Alfieri DF; Flauzino T; Junior PFG; Rossi DJ; Breganó JW; Simão ANC; de Almeida ERD; Lozovoy MAB; Reiche EMV
    Curr HIV Res; 2020; 18(4):292-306. PubMed ID: 32516102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical Cardiovascular Risk Factors and HIV are Associated With Carotid Intima-Media Thickness in Adults From Sub-Saharan Africa: Findings From H3Africa AWI-Gen Study.
    Nonterah EA; Boua PR; Klipstein-Grobusch K; Asiki G; Micklesfield LK; Agongo G; Ali SA; Mashinya F; Sorgho H; Nakanabo-Diallo S; Debpuur C; Kyobutungi C; Alberts M; Norris S; Tollman S; Tinto H; Soo CC; Mukomana F; Hazelhurst S; Wade AN; Kahn K; Oduro AR; Grobbee DE; Sankoh O; Ramsay M; Bots ML; Crowther NJ;
    J Am Heart Assoc; 2019 Jul; 8(14):e011506. PubMed ID: 31304842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk.
    Vos AG; Dodd CN; Delemarre EM; Nierkens S; Serenata C; Grobbee DE; Klipstein-Grobusch K; Venter WDF
    Front Immunol; 2021; 12():647805. PubMed ID: 34290695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of atherosclerosis in patients living with HIV.
    De Lorenzo F; Boffito M; Collot-Teixeira S; Gazzard B; McGregor JL; Shotliff K; Xiao H
    Vasc Health Risk Manag; 2009; 5(1):287-300. PubMed ID: 19436663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.